comparemela.com

Latest Breaking News On - Prostate urine risk - Page 1 : comparemela.com

Prostate cancer urine test identifies men who can safely avoid immediate treatment

Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid immediate treatment and benefit from 'active surveillance' instead.

Prostate cancer urine test identifies good prognosis patients

Thousands of men to trial new home test kit for prostate cancer

Thousands of men to trial new home test kit for prostate cancer Apr 30 2021 Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH). Image Credit: University of East Anglia The research team are trialing a new home-testing ‘Prostate Screening Box’ to collect men’s urine samples at-home. The urine samples will be used to analyze the health of the prostate in 2,000 men in the UK, Europe and Canada. This simple urine test is intended to diagnose aggressive prostate cancer and in a pilot study predicted which patients required treatment up to five years earlier than standard clinical methods.

Thousands of men to trial prostate cancer home testing kit

Thousands of men to trial prostate cancer home testing kit Published by  Thousands of men worldwide are to receive a home test kit for prostate cancer – thanks to pioneering research from the University of East Anglia and the Norfolk and Norwich University Hospital (NNUH). The research team are trialling a new home-testing ‘Prostate Screening Box’ to collect men’s urine samples at-home. The urine samples will be used to analyse the health of the prostate in 2,000 men in the UK, Europe and Canada. This simple urine test is intended to diagnose aggressive prostate cancer and in a pilot study predicted which patients required treatment up to five years earlier than standard clinical methods.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.